Whatsapp

Dzid 250mg Injection is effective in fighting against various types of bacteria preventing their growth This treatment helps to alleviate your symptoms and treat the underlying infection It is administered through intravenous infusion or direct injection into a vein or muscle under the supervision of a healthcare professional The appropriate dosage will be determined by your doctor It is important to use this medication consistently following the prescribed schedule Do not miss any doses and complete the entire course of treatment even if you start feeling better Discontinuing the medication too soon may result in a recurrence or worsening of the infection The most commonly experienced side effects of this medication are rash and diarrhea Some individuals may also experience temporary redness or pain at the injection site These side effects are typically mild but if they persist for more than a few days or cause significant discomfort inform your doctor Prior to using this medication inform your doctor about any allergies to antibiotics as well as any existing liver or kidney issues Additionally provide your healthcare team with a comprehensive list of all other medications you are currently taking as they may interact with or be influenced by this medication Pregnant or breastfeeding women should consult their doctor before using this medication

halth-assessment-tools

Available in 2 variations

thumbnail.svg

Dzid 1000mg Injection

Dzid 1000mg Injection

Ceftazidime (1000mg)

vial of 1 Injection

thumbnail.svg

Dzid 250mg Injection

Dzid 250mg Injection

Ceftazidime (250mg)

vial of 1 Injection

Written By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Reviewed By:

about-us.jpg

Published At: Dec 10, 2024

Updated At: Dec 26, 2024

Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.